BOLD - Audentes Therapeutics (BOLD) CEO Matt Patterson on Q3 2018 Results - Earnings Call Transcript
Audentes Therapeutics (BOLD)
Q3 2018 Earnings Conference Call
November 6, 2018 04:30 PM ET
Executives
Matt Patterson - President and CEO
Tom Soloway - SVP and CFO
Natalie Holles - President and COO
Suyash Prasad - SVP and CMO
Andrew Chang - Director of IR
Analysts
Ritu Baral - Cowen & Company
Ying Huang - Bank of America Merrill Lynch.
David Nierengarten - Wedbush Securities
Raju Prasad - William Blair
Reni Benjamin - Raymond James.
Matthew Luchini - BMO Capital Markets
Whitney Ijem - Guggenheim Securities
Difei Yang - Mizuho Securities
Presentation
Operator
Good day,